Influencing factors of contrast-induced nephropathy after percutaneous coronary intervention in elderly diabetic patients with acute coronary syndrome
Affiliation:

1.Department of Nephrology, ;2.Department of Cardiology, Central Hospital of Chengde, Chengde, Hebei 067000, China)

Clc Number:

R692

  • Article
  • | |
  • Metrics
  • |
  • Reference [29]
  • |
  • Related
  • | | |
  • Comments
    Abstract:

    Aim To find risk factors of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in elderly diabetic patients with acute coronary syndrome (ACS). Methods 134 cases of elderly diabetic patients with ACS (≥65 years old) was involved in this study. In the same period, 145 cases of PCI patients without diabetes were used as controls. The age, preoperation brain natriuretic peptide (BNP), ejection fraction, 25 hydroxyvitamin D, estimated glomerular filtration rate (eGFR), blood albumin and so on were compared between the two groups. Multifactor logistic regression analysis was used to find risk factors of CIN. Results 17 cases of CIN were found in 134 cases of patients with diabetes after PCI, the incidence was 12.6%. In 145 elderly patients without diabetes, there were 13 cases of CIN, with an incidence of 8.9%, there was no statistically significant difference between the two groups (P>0.05). Statistically difference was found in gender and perioperative use of ACEI/ARB between two groups (P<0.05). Preoperation BNP, fibrinogen, platelet volume distribution of the diabetes group was higher than non-diabetic, 25 hydroxyvitamin D was lower than non-diabetic group (P<0.05). Loistic regression analysis showed that fibrinogen and 25 hydroxyvitamin D were the risk factors of CIN for elderly diabetic patients with acute coronary syndrome after PCI. Preoperative fibrinogen elevation increased the risk of CIN (OR=3.3,5%CI 1.353~6.845, P=0.007), 25 hydroxyvitamin D reduction increased the risk of CIN (OR=0.5,5%CI 0.282~0.833, P=0.009). Conclusion The risk of CIN was increased when preoperative fibrin was elevated and 25 hydroxyvitamin D was decreased in elderly diabetes mellitus patients with acute coronary syndrome after PCI.

    Reference
    [1] Westenfeld R, Rump L C.Contrast induced nephropathy.Dtsch Mochenschr, 3,8(14):715-718.
    [2] Jorgensen A L.Contrast induced nephropthhy:pathophysiology and preventive strategies.Crit Care Nurse, 3,3(1):37-46.
    [3] 周希, 余红.血糖与冠状动脉介入治疗后造影剂肾病的相关性.中国老年学杂志, 4,4(14):3 861-862.
    [4] 陈文平, 冯烈.不同糖代谢及相关因素对造影剂肾病的影响.中国糖尿病杂志, 2,0(10):765-767.
    [5] 刘洁, 刘勉, 陈云爽.造影剂肾病高危因素及诊治的相关研究进展.解放军医药杂志, 7,9(7):112-116.
    [6] Stacul F, van der Molen A J, Reimer P, et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines.Eur Radiol, 1,1(12):2 527-541.
    [7] 段绍斌, 刘娜, 刘改灵, 等.造影剂肾病的发病机制及防治进展.医药导报, 4,3(4):415-418.
    [8] Cirit M, Toprak O, Yesil M, et al.Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy.Nephron Clin Pract, 6,4(1):20-27.
    [9] 郑桂安, 谢志艺, 陈建东, 等.培哚普利对冠脉介入术后对比剂肾病的影响.中国心血管病研究, 3,1(7):497-501.
    [10] Lainscak M, von-Haehling S, Anker SD.Natriuretic peptides and other biomarkers in chronic heart failure:from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.Int J Cardiol, 9,2(3):303-311.
    [11] 王建飞, 彭瑜, 张锦, 等.急性冠状动脉综合征患者大血小板比率与冠状动脉病变的相关性.临床心血管病杂志, 3,9(7):489-491.
    [12] Giuseppe De Luca, Matteo Santagostino, Gioel Gabrio Secco, et al.Platelet-large cell ratio and the extent of coronary artery disease:results from a large prospective study.J Thromb Thrombolysis, 0,0(4):426-433.
    [13] 王佃刚.急性冠状动脉综合征患者血清胆红素、尿酸及血浆纤维蛋白原浓度的变化及其临床意义.河南医学研究, 4,3(7):90-92.
    [14] Isordia-Salas I, Galvan-Plata ME, Leanos-Miranda A, et al.Proinflammatory and prothrombotic state in subjects with different glucose tolerance status before cardiovascular disease.J Diabetes Res, 4,4:631 902.
    [15] Dana H, Vanesa B, Aparna K, et al.Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury.Am J Pathol, 2,1(3):818-828.
    [16] 汪南平, 王新凤.维生素D在心血管疾病中的作用.生理科学进展, 3,4(3):223-226.
    [17] 方厚莹.25-羟基维生素D与缺血性卒中相关性研究进展.中华实用诊断与治疗杂志, 6,0(4):325-327.
    [18] de Boer IH, Ioannou GN, Kestenbaum B, et al.25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) .Am J Kidney Dis, 7,0(1):69-77.
    [19] Li Y C.Vitamin D receptor signaling in renal and cardiovascular protection.Semin Nephrol, 3,3(5):433-447.
    [20] Milos Mihajlovi, Michele Fedecostante, Miriam Oost, et al.Role of vitamin d in maintaining renal epithelial barrier function in uremic conditions.Int J Mol Sci, 7,8(12):2 531.
    [21] 李冬梅, 张颖, 丁波, 等.血清25羟维生素D缺乏与糖尿病肾病的关系.中华内科杂志, 2,2(11):970-974.
    [22] Mao L, Ji F, Liu Y, et al.Calcitrio l plays a protective role in diabetic nephropathy through anti-inflammatory effects.Int J Clin Exp Med, 4,7(12):5 437-444.
    [23] Luchi WM, Shimizu MH, Canale D, et al.Vitamin D deficiency is a potential risk factor for contrast-induced nephropathy.Am J Physiol Regul Integr Comp Physiol, 5,9(3):R215-222.
    [24] Sahin I, Gungor B, Can MM, et al.Low blood vitamin D levels are associated with an increased incidence of contrast-inducednephropathy in patients undergoing corcnary angiography.Am J Physiol Regul Integr Comp Physiol, 5,9(3):215-222.
    [25] Ari E, Kedrah AE, Alahdab Y, et al.Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model.Br J Radiol, 2,5(1016):1 038-043.
    [26] 王来亮, 高燕红, 罗群.慢性肾脏病患者维生素D缺乏与动脉僵硬度的相关性.中华肾脏病杂志, 5,1(1):24-31.
    [27] 左晓勇, 宋淑军, 司少艳, 等.维生素D对不同剂量X射线照射小鼠免疫功能的保护作用.中华放射医学与防护杂志, 6,6(4):268-271.
    [28] 肖颖, 董化江, 王正辉, 等.维生素D与慢性肾脏病研究进展.新乡医学院学报, 5,6(3):278.
    [29] Kim HS, Chung W, Kim S.Vitamin D, and kidney disease.Electrolyte Blood Press, 1,9(1):1-6.
    Related
    Cited by
Get Citation

WANG Yu-Hui, DONG Tie-Zhu, SONG Jing-Ying, WANG Hai-Feng, ZHOU Jiang. Influencing factors of contrast-induced nephropathy after percutaneous coronary intervention in elderly diabetic patients with acute coronary syndrome[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(4):389-393.

Copy
Share
Article Metrics
  • Abstract:1155
  • PDF: 0
  • HTML: 0
  • Cited by: 0
History
  • Received:December 06,2017
  • Revised:March 10,2018
  • Online: May 04,2018
Article QR Code